The short-chain fructooligosaccharides (scFOS) market is set to witness substantial growth by 2027 owing to surging global demand for nutritional dietary supplements.

Short-chain fructooligosaccharides (scFOS) are naturally occurring prebiotics, found in wheat, tomatoes, asparagus, chicory, and other vegetables and fruits. It is a common ingredient in dietary supplements as it promotes the production of microbiota in the gastrointestinal tract, thereby reducing intestinal ailments. Mounting incidences of infectious diseases around the world have reinforced the importance of consuming healthy food, which has driven the demand for scFOS in recent years.

Moreover, to benefit from emerging market trends, prominent industry players are employing lucrative expansion strategies, which has favorably altered the business landscape. For instance, in April 2021, Ingredion Incorporated, a leading ingredient solutions provider, announced the acquisition of KaTech, a German company specializing in stabilization and texturization solutions for the food industry. With the acquisition, Ingredion broadened its ingredients portfolio with a comprehensive range of innovative solutions.

In another instance, in March 2021, Meiji Co. Ltd., a Japan-based confectionery firm, and Danone, a global food company, launched infant formula milk in tablet format under Danone’s leading brand, Aptamil, in the UK. The infant formula tablets are easy to carry, hygienic, and eliminate the need to measure the supplement.

The short-chain fructooligosaccharides (scFOS) market has been segmented based on source, form, application, and region. With respect to source, the market has further been classified into sucrose and inulin. The sucrose sub-segment is anticipated to expand at a considerable pace over the review period owing to its wide-ranging applications in the food & beverage sector.

Based on application, the market has been divided into infant formula, food & beverage, animal feed, pharmaceuticals, and dietary supplements. The animal feed sub-segment is slated to witness steady growth through the forecast timeline. Extensive application of short-chain fructooligosaccharides (scFOS) as a prebiotic additive in the nutrition of pets and farm animals is likely to drive segmental expansion.

The short-chain fructooligosaccharides (scFOS) market from the pharmaceuticals sub-segment is foreseen to showcase robust growth through the analysis period on account of various health benefits of scFOS like reduced levels of cholesterol, phospholipids, and triglyceride.

From the regional point of view, the North America short-chain fructooligosaccharides (scFOS) market is set to gain significant traction over the study timespan. Rising consumer awareness about nutritional infant formula, beverages, and powered variants, is estimated to accelerate product demand in the region over the following years.

The Latin America short-chain fructooligosaccharides (scFOS) market is expected to observe optimistic growth over the assessment timeline due to prevalent product application in the food & beverage and cosmetics & personal care industries across Argentina, Mexico, and Brazil.

Meanwhile, the Middle East & Africa short-chain fructooligosaccharides (scFOS) market is speculated to see substantial growth in the wheat protein market by 2027 on account of increased sophistication in the food & beverage industry across key emerging economies in the region.